Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 11, 2015 - Issue
Submit an article Journal homepage
63
Views
7
CrossRef citations to date
0
Altmetric
Review

Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis

Eleonora CoccoMultiple Sclerosis Center, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Cagliari, ItalyCorrespondence[email protected]
&
Maria Giovanna MarrosuMultiple Sclerosis Center, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Cagliari, Italy
Pages 759-766 | Published online: 08 May 2015

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Kendra L Furber, Marina Van Agten, Charity Evans, Azita Haddadi, J Ronald Doucette & Adil J Nazarali. (2017) Advances in the treatment of relapsing–remitting multiple sclerosis: the role of pegylated interferon β-1a. Degenerative Neurological and Neuromuscular Disease 7, pages 47-60.
Read now

Articles from other publishers (6)

Vasileios-Periklis Stamatellos & Georgios Papazisis. (2023) Safety and Monitoring of the Treatment with Disease-Modifying Therapies (DMTs) for Multiple Sclerosis (MS). Current Reviews in Clinical and Experimental Pharmacology 18:1, pages 39-50.
Crossref
Thelvia I. Ramos, Carlos A. Villacis-Aguirre, Nelson Santiago Vispo, Leandro Santiago Padilla, Seidy Pedroso Santana, Natalie C. Parra & Jorge Roberto Toledo Alonso. (2021) Forms and Methods for Interferon’s Encapsulation. Pharmaceutics 13:10, pages 1533.
Crossref
Barbara Spolaore, Giacomo Forzato & Angelo Fontana. (2018) Site-specific derivatization of human interferon β-1a at lysine residues using microbial transglutaminase. Amino Acids 50:7, pages 923-932.
Crossref
Giancarlo Coghe, Laura Atzori, Jessica Frau, Giuseppe Fenu, Lorena Lorefice, Maria Giovanna Marrosu & Eleonora Cocco. (2017) Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection. Multiple Sclerosis Journal 24:2, pages 231-233.
Crossref
E. V. Popova, K. V. Novikova, N. V. Khachanova, O. E. Konovalova, M. Kh. Kozhieva, M. V. Davydovskaya & A. N. Boyko. (2017) The search for optimal decision in the treatment of multiple sclerosis: to improve adherence not reducing the efficacy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 117:10, pages 48.
Crossref
Mitra Habibi & Huda-Marie Kuttab. (2016) Management of multiple sclerosis and the integration of related specialty pharmacy programs within health systems. American Journal of Health-System Pharmacy 73:11, pages 811-819.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.